Genome editing iPSC to purposing enhancement of induce CD8 killer T cell function for regenerative immunotherapy
Abstract In recent years, immunotherapy has become a standard cancer therapy, joining surgery, chemotherapy, and radiation therapy. This therapeutic approach involves the use of patient-derived antigen-specific T cells or genetically modified T cells engineered with chimeric antigen receptors (CAR)...
Saved in:
Main Authors: | Sota Kurihara (Author), Akihiro Ishikawa (Author), Shin Kaneko (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Regenerative therapy for spinal cord injury using iPSC technology
by: Narihito Nagoshi, et al.
Published: (2020) -
Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
by: Takahiro Aoki, et al.
Published: (2023) -
iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity
by: Tim Y. T. Lee, et al.
Published: (2024) -
Studies on immune regulation for allogeneic iPSC-based transplantation
by: Ken-ichiro Seino
Published: (2022) -
Ergothioneine-Mediated Neuroprotection of Human iPSC-Derived Dopaminergic Neurons
by: Damien Meng-Kiat Leow, et al.
Published: (2024)